The Annual General Meeting of Targovax ASA (the “Company”) will be held at the Company’s offices at Lysaker, on 30 April 2019 at 13:00 CET.
Please find the notice including agenda for the General Meeting and appendices attached to this disclosure. The notice and appendices will also be made available on Targovax’ website https://www.targovax.com/en/section/governance/general-meetings/.
Notice of attendance must be received no later than 29 April 2019 at 16:00 CET.
Reference is also made to the Company’s stock exchange announcement on 27 March 2019 regarding the terms and conditions for the proposed subsequent offering in the Company. The Company’s board of directors has proposed to re-schedule the subscription period in the subsequent offering, since the Company expects to read out 3-year survival data for TG01 during this new subscription period. The re-scheduled subscription period will commence at 09:00 hours (CEST) on 10 May 2019 and expire at 16:30 hours (CEST) on 24 May 2019.
For further information, please contact:
Renate Birkeli, Investor Relations
Phone: +47 922 61 624
Media and IR enquires:
Andreas Tinglum – Corporate Communications (Norway)
Phone: +47 9300 1773